| * Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells |
| * GPR109A (PUMA-G/HM74A) mediates nicotinic acid–induced flushing |
| * Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor |
| * Cross-reactive influenza virus–specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus–associated infectious mononucle |
| * Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis |
| * Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents |
| * Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight |
| * Mice lacking ghrelin receptors resist the development of diet-induced obesity |
| * The mitochondrial origin of postischemic arrhythmias |
| * Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors |
| * Brain glucagon-like peptide–1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage |
| * CD4+ T cell–independent DNA vaccination against opportunistic infections |
| * Absence of ghrelin protects against early-onset obesity |
| * A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemi |
| * Timp3 deficiency in insulin receptor–haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF- |
| * Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes |
| * Preferential migration of effector CD8+ T cells into the interstitium of the normal lung |
| * Role of CCR5 in IFN-–induced and cigarette smoke–induced emphysema |
| * M-CSF mediates TNF-induced inflammatory osteolysis |
| * Expanding the immunotherapeutic potential of minor histocompatibility antigens |
| * Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid |
| * Desperately seeking sugar: glial cells as hypoglycemia sensors |
| * New ways in which GLP-1 can regulate glucose homeostasis |
| * Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin |
| * Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia |
| * Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays |
| * Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases |
| * New ways in which GLP-1 can regulate glucose homeostasis |
| * In this issue |
| * Is ghrelin a signal for the development of metabolic systems? |
| * Minding the gaps to promote thrombus growth and stability |
| * Platelets in inflammation and atherogenesis |
| * Platelet genomics and proteomics in human health and disease |
| * Structure and function of the platelet integrin IIb?3 |
| * Thrombus formation in vivo |
| * The biogenesis of platelets from megakaryocyte proplatelets |
| * The molecular mechanisms that control thrombopoiesis |
| * Megakaryocyte biology and related disorders |
| * Did dinosaurs have megakaryocytes? New ideas about platelets and their progenitors |
| * Pathogenesis of osteoporosis: concepts, conflicts, and prospects |
| * The L-type calcium channel in the heart: the beat goes on |
| * Murderous medicine: |
| * Fatal sequence: |
| * Taking the direct route to make open access even easier |
| * Hopkins scientist tunes in to treat tuberculosis |
| * Essential Neurology, 4th edition |
| * Volume 76 Reviewers |
| * Volume 76 Assessors |
| * CORRECTION |
| * Ultra fast resolution of acute post-traumatic subdural haematoma |
| * Vis attractiva and vis nervosa |
| * Psychiatry, third edition, Oxford core texts |
| * Mechanism and management of headache, seventh edition |
| * Oxford handbook of psychiatry |
| * The Auditory Cortex, A Synthesis of Human and Animal Research |
| * A historical dictionary of psychiatry |
| * Lecture Notes: Neurology, 8th edition |
| * Myology, third edition |
| * A case of superior cerebellar artery syndrome with contralateral hearing loss at onset |
| * Video assessment of rTMS for Tourette syndrome |
| * Ocular tilt reaction and anterior inferior cerebellar artery syndrome |
| * Disseminated Pseudallescheria boydii infection successfully treated with voriconazole |
| * Laryngeal abductor paralysis can be a solitary manifestation of multiple system atrophy |
| * "Who came with you?" A diagnostic observation in patients with memory problems? |
| * Ambiguous value of Haemophilus influenzae isolation in Guillain-Barré and Fisher syndromes |
| * Efficacy of TNF blockade in cyclophosphamide resistant neuro-Beh?et disease |
| * Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura |
| * Unidirectional whole body turning: a new lateralising sign in complex partial seizures |
| * Baló’s concentric sclerosis associated with primary human herpesvirus 6 infection |
| * Spinocerebellar ataxia type 14: study of a family with an exon 5 mutation in the PRKCG gene |
| * Acanthocytosis as a predisposing factor for non-ketotic hyperglycaemia induced chorea-ballism |
| * Pallidal stimulation in dystonia: effects on cognition, mood, and quality of life |
| * The James Lind Library: http://www.jameslindlibrary.org/ |
| * Validation of a short disease specific quality of life scale for hemifacial spasm: correlation with SF-36 |
| * Antinuclear antibodies define a subgroup of paraneoplastic neuropathies: clinical and immunological data |
| * -Methionine PET: dysembryoplastic neuroepithelial tumours compared with other epileptogenic brain neoplasms |
| * Peripheral neuropathy in metachromatic leucodystrophy. A study of 40 cases from south India |
| * Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease |
| * The safety of antiepileptic drug withdrawal in patients with non-epileptic seizures |
| * Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use |
| * Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple scleros |
| * Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up |
| * Pathogenesis of deep white matter medullary infarcts: a diffusion weighted magnetic resonance imaging study |
| * Do stroke patients with normal carotid arteries require TEE for exclusion of relevant aortic plaques? |
| * Influence of pre-existing dementia on the risk of post-stroke epileptic seizures |
| * When is Onuf’s nucleus involved in multiple system atrophy? A sphincter electromyography study |
| * Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow up |
| * Metacognitive deficits in frontotemporal dementia |
| * Modafinil for daytime somnolence in Parkinson’s disease: double blind, placebo controlled parallel trial |
| * Non-invasive brain stimulation for Parkinson’s disease: a systematic review and meta-analysis of the literature |
| * Lipid lowering agents are associated with a slower cognitive decline in Alzheimer’s disease |
| * Withdrawal of antiepileptic drugs in people with non-epileptic seizures |
| * Cannabinoids in multiple sclerosis: urgent need for long term trials |
| * Lipid lowering agents to delay cognitive decline in Alzheimer’s disease? |